✦ LIBER ✦

A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis

✍ Scribed by D. L. Trump; David C. Smith; Dwight Stiff; Adedayo Adedoyin; Roger Day; Robert R. Bahnson; Janie Hofacker; Robert A. Branch

Publisher: Springer
Year: 1997
Tongue: English
Weight: 199 KB
Volume: 39
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800050582

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and clinical impact of

Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial

✍ Linda M. Sutton; Marc A. Warmuth; William P. Petros; Eric P. Winer 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 155 KB

A phase II trial of CI-958 in patients w

A phase II trial of CI-958 in patients with hormone-refractory prostate cancer

✍ Paul V. Woolley; Fuad S. Freiha; David C. Smith; Lynn Carlson; Janie Hofacker; N 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 209 KB

A phase II trial of docetaxel and vinore

A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer

✍ Susan Goodin; Kamakshi V. Rao; Michael Kane; Nisha Dave; Terry Capanna; Susan Do 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 200 KB

A phase II trial of estramustine and eto

A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407)

✍ Kenneth J. Pienta; Emily I. Fisher; Mario A. Eisenberger; Glenn M. Mills; J. Wen 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

BACKGROUND. The combination of oral estramustine and oral etoposide has generated response rates of 40±50% in patients with hormone refractory prostate cancer in single institution trials. This study tested this regimen in a multi-institutional setting. METHODS. Fifty-®ve patients were accrued over

A phase II trial of dexamethasone, vitam

A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer

✍ Thomas W. Flaig; Albaha Barqawi; Gary Miller; Madeleine Kane; Chan Zeng; E. Davi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

Phase I clinical trial of all-trans-reti

Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics

✍ B. A. Conley; Merrill J. Egorin; Rajeshwari Sridhara; Rebecca Finley; Ramzi Hema 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 200 KB